Login / Signup

Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.

Adithya BalasubramanianAshray GunjurUmbreen HafeezSiddharth MenonLawrence M CherSagun ParakhHui Kong Gan
Published in: Neuro-oncology advances (2020)
Our findings highlight the critical role of optimally designed phase II trials in informing drug development for GBM.
Keyphrases
  • phase ii
  • phase iii
  • open label
  • clinical trial
  • placebo controlled
  • double blind
  • study protocol
  • randomized controlled trial